Author:
McIlleron Helen,Willemse Marianne,Schaaf Hendrik Simon,Smith Peter John,Donald Peter Roderick
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health
Reference12 articles.
1. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide.;Am Rev Respir Dis,1991
2. Therapeutic drug monitoring: principles and application in mycobacterial infections.;Peloquin;Drug Ther,1992
3. Isoniazid, rifampicin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana.;Chideya;Clin Infect Dis,2009
4. Rifampin plasma concentrations in children, with and without human immunodeficiency virus infection, hospitalized for the management of severe forms of tuberculosis.;Schaaf;BMC Med,2009
5. Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines.;McIlleron;Clin Infect Dis,2009
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献